CREB1 and renal cell adenocarcinoma: RCC cell line proliferation in vitro was reduced with siSKA2, and this effect was reversed by ectopic administration of CREB, also decreasing the siSKA2 effect of holding numbers of cells in mitosis (Figure 4).